JP2016510989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510989A5 JP2016510989A5 JP2015562528A JP2015562528A JP2016510989A5 JP 2016510989 A5 JP2016510989 A5 JP 2016510989A5 JP 2015562528 A JP2015562528 A JP 2015562528A JP 2015562528 A JP2015562528 A JP 2015562528A JP 2016510989 A5 JP2016510989 A5 JP 2016510989A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- administration
- poxvirus
- nucleic acid
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2013/055409 | 2013-03-15 | ||
| PCT/EP2013/055409 WO2014139587A1 (en) | 2013-03-15 | 2013-03-15 | Improved poxviral vaccines |
| PCT/IB2014/059802 WO2014141176A1 (en) | 2013-03-15 | 2014-03-14 | Improved poxviral vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510989A JP2016510989A (ja) | 2016-04-14 |
| JP2016510989A5 true JP2016510989A5 (https=) | 2017-04-13 |
| JP6702725B2 JP6702725B2 (ja) | 2020-06-03 |
Family
ID=47882194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015562528A Expired - Fee Related JP6702725B2 (ja) | 2013-03-15 | 2014-03-14 | 改良されたポックスウイルスワクチン |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20160000904A1 (https=) |
| EP (1) | EP2968493B1 (https=) |
| JP (1) | JP6702725B2 (https=) |
| CN (2) | CN109182378A (https=) |
| BE (1) | BE1021192B1 (https=) |
| BR (1) | BR112015023524B1 (https=) |
| CA (1) | CA2907026A1 (https=) |
| CY (1) | CY1120740T1 (https=) |
| DK (1) | DK2968493T3 (https=) |
| ES (1) | ES2685922T3 (https=) |
| HR (1) | HRP20181376T1 (https=) |
| HU (1) | HUE040189T2 (https=) |
| LT (1) | LT2968493T (https=) |
| PL (1) | PL2968493T3 (https=) |
| PT (1) | PT2968493T (https=) |
| SI (1) | SI2968493T1 (https=) |
| WO (2) | WO2014139587A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10576143B2 (en) | 2013-03-15 | 2020-03-03 | Glaxosmithkline Biologicals Sa | Poxviral vaccines |
| WO2014139587A1 (en) | 2013-03-15 | 2014-09-18 | Okairòs Ag | Improved poxviral vaccines |
| GB201321384D0 (en) * | 2013-12-04 | 2014-01-15 | Isis Innovation | Molecular adjuvant |
| WO2017025782A1 (en) * | 2014-09-17 | 2017-02-16 | Glaxosmithkline Biologicals Sa | Improved poxviral vaccines |
| KR20180004820A (ko) | 2015-05-15 | 2018-01-12 | 큐어백 아게 | 적어도 하나의 mRNA 구성의 투여를 포함하는 신규 프라임-부스트 요법 |
| MX2019002178A (es) * | 2016-08-23 | 2019-09-18 | Glaxosmithkline Biologicals Sa | Peptidos de fusion con antigenos enlazados a fragmentos cortos de cadena invariante (cd74). |
| GB201704417D0 (en) | 2017-03-20 | 2017-05-03 | Univ Copenhagen | Improved li vaccine adjuvant |
| JP7298926B2 (ja) * | 2017-07-12 | 2023-06-27 | ノイスコム アーゲー | 癌の治療のためのネオアンチゲンワクチン組成物 |
| GB201721068D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B immunisation regimen and compositions |
| GB201721069D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B Immunisation regimen and compositions |
| GB201812647D0 (en) * | 2018-08-03 | 2018-09-19 | Chancellor Masters And Scholars Of The Univ Of Oxford | Viral vectors and methods for the prevention or treatment of cancer |
| US20210283238A1 (en) | 2018-08-07 | 2021-09-16 | Glaxosmithkline Biologicals Sa | Novel processes and vaccines |
| EP3897846A1 (en) * | 2018-12-21 | 2021-10-27 | GlaxoSmithKline Biologicals SA | Methods of inducing an immune response |
| TW202102256A (zh) | 2019-03-05 | 2021-01-16 | 比利時商葛蘭素史密斯克藍生物品公司 | B型肝炎免疫法及組合物 |
| CN111057716B (zh) * | 2019-07-27 | 2022-04-15 | 中国人民解放军军事科学院军事医学研究院 | 用于包装重组人4型腺病毒的单质粒载体系统及其应用 |
| WO2024133160A1 (en) | 2022-12-19 | 2024-06-27 | Glaxosmithkline Biologicals Sa | Hepatitis b compositions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1272179B (it) | 1994-02-23 | 1997-06-16 | Angeletti P Ist Richerche Bio | Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv. |
| IT1278077B1 (it) | 1995-05-25 | 1997-11-17 | Angeletti P Ist Richerche Bio | Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal |
| GB9711957D0 (en) * | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| CA2461380C (en) | 2001-10-11 | 2011-03-22 | Merck & Co., Inc. | Hepatitis c virus vaccine |
| CN102703393A (zh) * | 2002-05-16 | 2012-10-03 | 巴法里安诺迪克有限公司 | 表达插入痘病毒基因组中的同源基因的重组痘病毒 |
| ATE449105T1 (de) | 2004-01-23 | 2009-12-15 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| EP1957528B1 (en) | 2005-11-30 | 2012-11-07 | University of Copenhagen | A nucleotide vaccine |
| HUE045093T2 (hu) * | 2008-11-21 | 2019-12-30 | Kobenhavns Univ University Of Copenhagen | Immunválasz kiváltása |
| EP2391638B1 (en) | 2009-02-02 | 2018-06-27 | GlaxoSmithKline Biologicals SA | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| WO2014139587A1 (en) | 2013-03-15 | 2014-09-18 | Okairòs Ag | Improved poxviral vaccines |
| US10576143B2 (en) * | 2013-03-15 | 2020-03-03 | Glaxosmithkline Biologicals Sa | Poxviral vaccines |
| GB201321384D0 (en) | 2013-12-04 | 2014-01-15 | Isis Innovation | Molecular adjuvant |
| MX2019002178A (es) | 2016-08-23 | 2019-09-18 | Glaxosmithkline Biologicals Sa | Peptidos de fusion con antigenos enlazados a fragmentos cortos de cadena invariante (cd74). |
-
2013
- 2013-03-15 WO PCT/EP2013/055409 patent/WO2014139587A1/en not_active Ceased
-
2014
- 2014-03-14 CN CN201811100700.2A patent/CN109182378A/zh active Pending
- 2014-03-14 CA CA2907026A patent/CA2907026A1/en active Pending
- 2014-03-14 BR BR112015023524-7A patent/BR112015023524B1/pt not_active IP Right Cessation
- 2014-03-14 HU HUE14723475A patent/HUE040189T2/hu unknown
- 2014-03-14 US US14/770,510 patent/US20160000904A1/en not_active Abandoned
- 2014-03-14 BE BE2014/0166A patent/BE1021192B1/fr not_active IP Right Cessation
- 2014-03-14 PT PT14723475T patent/PT2968493T/pt unknown
- 2014-03-14 HR HRP20181376TT patent/HRP20181376T1/hr unknown
- 2014-03-14 SI SI201430827T patent/SI2968493T1/sl unknown
- 2014-03-14 DK DK14723475.1T patent/DK2968493T3/en active
- 2014-03-14 ES ES14723475.1T patent/ES2685922T3/es active Active
- 2014-03-14 WO PCT/IB2014/059802 patent/WO2014141176A1/en not_active Ceased
- 2014-03-14 LT LTEP14723475.1T patent/LT2968493T/lt unknown
- 2014-03-14 EP EP14723475.1A patent/EP2968493B1/en active Active
- 2014-03-14 JP JP2015562528A patent/JP6702725B2/ja not_active Expired - Fee Related
- 2014-03-14 PL PL14723475T patent/PL2968493T3/pl unknown
- 2014-03-14 CN CN201480015680.2A patent/CN105307674A/zh active Pending
-
2017
- 2017-12-20 US US15/848,100 patent/US10588961B2/en active Active
-
2018
- 2018-08-14 CY CY181100859T patent/CY1120740T1/el unknown
-
2020
- 2020-02-05 US US16/782,268 patent/US11278614B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510989A5 (https=) | ||
| ES2800623T3 (es) | Promotor PR13.5 para respuestas contundentes de células T y anticuerpos | |
| Herbert et al. | Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR | |
| Verardi et al. | A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication | |
| EP1616954B1 (en) | Methods and reagents for vaccination which generate a CD8+ Tcell immune response against hepatitis B or C | |
| Schneider et al. | Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies | |
| MX2022009962A (es) | Vacunas y usos de la mismas para inducir una respuesta inmunitaria al sars-cov-2. | |
| JP2014503206A5 (https=) | ||
| JP2015533841A5 (https=) | ||
| AU2002347317B2 (en) | Vaccine | |
| US20160304582A1 (en) | Molecular adjuvant | |
| JP2020516264A5 (https=) | ||
| JP2013507907A5 (https=) | ||
| SG10201901735XA (en) | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine | |
| CA3067405A1 (en) | Personalized vaccine comprising a recombinant poxvirus expressing a fusioin of nepopeptides | |
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| RU2019107976A (ru) | Композиция вакцины | |
| JP6851364B2 (ja) | ポックスウイルスにおける発現を増強するためのプロモーター | |
| JP2016510989A (ja) | 改良されたポックスウイルスワクチン | |
| JP2012515557A5 (https=) | ||
| EA201890042A1 (ru) | Вакцина против вируса ящура (вя) на основе рекомбинантного модифицированного вируса осповакцины анкара (mva) | |
| JP2017527568A (ja) | フィロウイルス感染に対する防御免疫の誘導を目的とする方法及び組成物 | |
| JP2017503479A (ja) | ポックスウイルスベクターを用いて増強された免疫応答を誘導するための組成物及び方法ベクター | |
| JP2018521651A5 (https=) | ||
| JP2016074727A5 (https=) |